Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review

MH Elkomy, AA Ali, HM Eid - Journal of Controlled Release, 2022 - Elsevier
The ability of chitosan (CTS) to promote mucoadhesion, trigger positive/negative surface
interactions, and open tight junctions has inspired researchers to coat lipid-based and …

Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health

J Zhang, K Hu, L Di, P Wang, Z Liu, J Zhang… - Advanced drug delivery …, 2021 - Elsevier
Traditional herbal medicine (THM), an ancient science, is a gift from nature. For thousands of
years, it has helped humans fight diseases and protect life, health, and reproduction …

Chitosan as a coating material for nanoparticles intended for biomedical applications

LA Frank, GR Onzi, AS Morawski, AR Pohlmann… - Reactive and Functional …, 2020 - Elsevier
This review provides a comprehensive and updated overview of the state of the art related to
the biomedical applications of nanoparticles coated with chitosan. Discussions were based …

Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin

LC Tsai, CH Chen, CW Lin, YC Ho, FL Mi - International journal of …, 2019 - Elsevier
Oral administration is a highly attractive approach for the delivery of protein drugs. However,
oral protein therapeutics typically exhibit extremely poor bioavailability due to the harsh …

Use of natural products in leishmaniasis chemotherapy: an overview

LFO Gervazoni, GB Barcellos, T Ferreira-Paes… - Frontiers in …, 2020 - frontiersin.org
Leishmaniasis is an infectious parasitic disease that is caused by protozoa of the genus
Leishmania, a member of the Trypanosomatidae family. Leishmaniasis is classified by the …

Applications of nanomaterials in leishmaniasis: a focus on recent advances and challenges

K Saleem, Z Khursheed, C Hano, I Anjum, S Anjum - Nanomaterials, 2019 - mdpi.com
Leishmaniasis is a widely distributed protozoan vector-born disease affecting almost 350
million people. Initially, chemotherapeutic drugs were employed for leishmania treatment but …

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight

H Jamshaid, FU Din, GM Khan - Journal of Nanobiotechnology, 2021 - Springer
As a neglected tropical disease, Leishmaniasis is significantly instigating morbidity and
mortality across the globe. Its clinical spectrum varies from ulcerative cutaneous lesions to …

Recent advancement in chitosan-based nanoparticles for improved oral bioavailability and bioactivity of phytochemicals: Challenges and perspectives

SS Imam, S Alshehri, MM Ghoneim, A Zafar… - Polymers, 2021 - mdpi.com
The excellent therapeutic potential of a variety of phytochemicals in different diseases has
been proven by extensive studies throughout history. However, most phytochemicals are …

Preparation and characterization of chitosan-coated nanostructured lipid carriers (CH-NLC) containing cinnamon essential oil for enriching milk and anti-oxidant …

S Bashiri, B Ghanbarzadeh, A Ayaseh, J Dehghannya… - Lwt, 2020 - Elsevier
The cinnamon essential oil (CEO) was loaded in nanostructured lipid carriers (NLC) and
NLC surfaces were coated with chitosan (CH-NLC). The particle size increased significantly …

Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis

AS Khan, F ud Din, Z Ali, M Bibi, F Zahid, A Zeb… - International journal of …, 2021 - Elsevier
The purpose of this study was to enhance the anti-leishmanial efficacy of miltefosine (MTF)
and reduce its toxic effects by loading it into nanostructured lipid carriers (NLCs). Micro …